CTRI/2017/08/009476进行中（未招募）未知
Monitoring of anti-Xa levels following extended duration of thromboprophylaxis with enoxaparin in morbidly obese patients undergoing laparoscopic bariatric surgery
arani KK0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients with morbid obesity (BMI more than 40 Kg/m2 or BMI more than 35 Kg/m2 with an obesity related co-morbidity), undergoing laparoscopic bariatric surgery
排除标准
- •1. Patients on anticoagulants or antiplatelet drugs
- •2. Patients with h/o DVT and PE
- •3. Chronic liver disease (serum bilirubin above 2mg/dl)
- •4. Chronic renal disease (Cr Cl less than 30ml/min)
研究者
相似试验
已完成
不适用
The serum anti-Xa activity monitoringatrial fibrillationJPRN-UMIN000020761Keio University School of Medicine100
招募中
不适用
Analysis of Anti-Xa-Levels prior to neuroaxial blocks - a retrospective studyD68.9Coagulation defect, unspecifiedDRKS00022099Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Freiburg100
已完成
不适用
Anti-Xa activity after a reduced therapeutic dose of nadroparin in patients with renal impairment using a dosage guideline of the Dutch Federation of NephrologyRenal impairment10038430coagulation10014523NL-OMON44475Medisch Centrum Leeuwarden194
Unknown
不适用
Anti-Xa activity of nadroparin after a dose reduction (XANDO)Renal impairmentVenous thromboembolism NierinsufficiëntieVeneuze trombo-embolieNL-OMON23816Medisch Centrum Leeuwarden194
终止
4 期
Residual Anti-Xa Activity After Last Treatment Dose of EnoxaparinAnticoagulants and Bleeding DisordersSurgeryRegional Anesthesia MorbidityNCT03296033Wake Forest University Health Sciences122